Đang chuẩn bị nút TẢI XUỐNG, xin hãy chờ
Tải xuống
Fabry disease (FD) is an X-linked lysosomal storage disorder resulting from the α-galactosidase A gene mutations. Enzyme-replacement-therapy (ERT) products for FD currently used include agalsidase alfa and agalsidase beta. | Efficacy and safety of enzyme-replacementtherapy with agalsidase alfa in 36 treatment-naïve Fabry disease patients